2HAAS C. Pulmonary hypertension associated with systemic lupus erythematosus [ J]. Bull Acad Natl Med (法文), 2004, 188 (6): 985-987.
3DORFMU LLER P, HUMBERT M, PERROS F. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases[J]. Hum Pathol, 2007, 38 (6): 893 -902.
4CHEEVER K H. An overview of pulmonary arterial hypertension : risks, pathogenesis, clinical manifestations, and management[ J]. J Cardiovasc Nurs, 2005, 20 (2): 108-116.
5PEREZ-VILLA F, FONT J, AZQUETA M, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study[ J]. Arthritis Rheum, 2005, 53 (3) : 460-467.
6RODRIGUEZ-VITA J, RUIZ-ORTEGA M, RUPEREZ M, et al. Endothelin-1, via ETA receptor and inde- pendently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells[J]. Circ Res, 2005, 97 (2): 125-134.
7HOUMAN M H, SMITI-KHANFIR M, BEN GHORBELL I, et al. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients [J]. Lupus, 2004, 13 (3): 204-211.
8GONZALEZ-LOPEZ L, CARDONA-MUNOZ E G, CELIS A, et al. Therapy with intermittent pulse cyelo- phosphamide for pulmonary hypertension associated with systemic lupus erythematosus [ J ]. Lupus, 2004, 13 (2) : 105-112.
5HELLER T, AHMED M, SIDDIQQI A, et al. Systemic lupus eryhematosus in Saud Arabia: morbidity and mor- tality in a multiethnic population [ J ]. Lupus, 2007, 16 (11) : 908-914.
6NOSSENT J, CIKES N, MARCHESONI A, et al. Cur- rent causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and dam- age accrual[J]. Lupus, 2007, 16 (5): 309-317.
7RABBANI M A, HABIB H B, ISLAM M, et al. Early re- nal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan [J]. Lupus, 2010, 19 (13): 1573-1578.
8AL-RAYES H, ALSWAILEM R, ARFIN M, et al. Sys- temic lupus erythematosus and infections: a retrospective study in Saudis[J]. Lupus, 2007, 16 (9) : 755-763.
10Out H J, de Gooot PG, Hasseiaar P, et al. Flactuation of anti- cardiolpin antibody Llevels in patients wint SLE: Aprospec- tive study. Ann Rheum Dis, 1989,48 : 1 024.
